Article ID Journal Published Year Pages File Type
5678501 Contemporary Clinical Trials 2017 7 Pages PDF
Abstract
We observe that I-SPY 2 possesses several novel features that could be used as a template for more efficient and cost effective drug development, namely its adaptive trial design; precompetitive network of stakeholders; and flexible infrastructure to accommodate innovation.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Preview
Re-inventing drug development: A case study of the I-SPY 2 breast cancer clinical trials program
Authors
, ,